8 January 2014
TPG Capital’s stalled sale process for drugmaker Aptalis Pharma could be back on after it emerged previously interested party Forest Laboratories was nearing a $3bn buyout.
Read full story
We're opening doors online to connect LPs & GPs worldwide
Already a member? LOG IN HERE
Thousands of LPs
Thousands of GPs
One LP-GP Network
The outlook for infrastructure private equity and venture industry - from the latest AltAssets' LP-GP Forum
Limited Partners want as much as 50 per cent of their PE exposure in direct investments. Is there any chance of their wishes being fulfilled – and what will it mean for the LP-GP relationship?
AltAssets is registered as a trademark of Investor Networks Limited (06695690).Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJContent is © AltAssets 2000-2015